Finance

Lists
LOVE:TSE
Cannara Biotech Inc
CAD 2,04
+2,00%
(+0,040) 1D
20 Okt., 12:11:27 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for LOVE...
Open
CAD 2,06
High
CAD 2,06
Low
CAD 2,00
Mkt. cap
201,08 m
Avg. vol.
47,90 k
Volume
17,06 k
P/E ratio
18,32
52-wk high
CAD 2,37
52-wk low
CAD 1,55
EPS
CAD 0,11
Beta
0,29
Shares outstanding
98,78 m
No. of employees
452
Open
CAD 2,06
High
CAD 2,06
Low
CAD 2,00
Mkt. cap
201,08 m
Avg. vol.
47,90 k
Volume
17,06 k
P/E ratio
18,32
52-wk high
CAD 2,37
52-wk low
CAD 1,55
EPS
CAD 0,11
Beta
0,29
Shares outstanding
98,78 m
No. of employees
452
News stories
From web sources and news partners
About Cannara Biotech Inc
CEO-
Employees452
Founded2017
Headquarters-
SectorPersonal care products
Websitecannara.ca
Last report
15 Jul. 2026
Fiscal period
Q3 2026
CAD 0,04 / CAD 0,04
+11,14%beat
Revenue / Est. (CAD)
31,83 m / 31,23 m
+1,90%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Aug. 2025
Nov. 2025
Feb. 2026
Mei 2026
Revenue
28,52 m
30,11 m
27,18 m
31,83 m
Cost of goods sold
16,13 m
18,90 m
15,53 m
16,80 m
Cost of revenue
16,13 m
18,90 m
15,53 m
16,80 m
Research and development expenses
191,15 k
287,45 k
400,70 k
344,72 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,02 m
6,23 m
6,50 m
6,30 m
Operating expense
7,30 m
8,51 m
8,25 m
7,67 m
Total operating expenses
23,43 m
27,41 m
23,78 m
24,47 m
Operating income
5,09 m
2,70 m
3,40 m
7,36 m
Other non operating income
-379,12 k
-73,54 k
-126,60 k
-113,09 k
EBT including unusual items
4,54 m
2,04 m
2,82 m
6,87 m
EBT excluding unusual items
4,00 m
2,04 m
2,94 m
6,87 m
Income tax expense
1,23 m
1,00 m
1,16 m
2,03 m
Effective tax rate
27,03%
49,07%
41,04%
29,54%
Other operating expenses
-
-
-
-
Net income
3,31 m
1,04 m
1,66 m
4,84 m
Net profit margin
11,62%
3,45%
6,12%
15,21%
Earnings per share
-
-
0,02
0,04
Interest and investment income
89,58 k
82,70 k
84,27 k
141,63 k
Interest expense
-805,27 k
-608,11 k
-465,53 k
-492,85 k
Net interest expenses
-715,69 k
-525,41 k
-381,26 k
-351,22 k
Depreciation and amortization charges
-
266,74 k
252,99 k
238,30 k
EBITDA
7,26 m
4,22 m
4,64 m
8,93 m
Gain or loss from assets sale
-422,17 k
-
122,01 k
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme